Search

everythinglearnresearchcommunity

for

Search:↓

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Both estrogens and androgens are important for health in both males and females.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

No link found between specific genes and female pattern hair loss.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

Anabolic steroid users may face higher risk of severe COVID-19.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.